Meta-evaluation of a whole systems programme, ActEarly: A study protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 06 01 2023
accepted: 19 05 2023
medline: 5 6 2023
pubmed: 1 6 2023
entrez: 1 6 2023
Statut: epublish

Résumé

Living in an area with high levels of child poverty predisposes children to poorer mental and physical health. ActEarly is a 5-year research programme that comprises a large number of interventions (>20) with citizen science and co-production embedded. It aims to improve the health and well-being of children and families living in two areas of the UK with high levels of deprivation; Bradford in West Yorkshire, and the London Borough of Tower Hamlets. This protocol outlines the meta-evaluation (an evaluation of evaluations) of the ActEarly programme from a systems perspective, where individual interventions are viewed as events in the wider policy system across the two geographical areas. It includes investigating the programme's impact on early life health and well-being outcomes, interdisciplinary prevention research collaboration and capacity building, and local and national decision making. The ActEarly meta-evaluation will follow and adapt the five iterative stages of the 'Evaluation of Programmes in Complex Adaptive Systems' (ENCOMPASS) framework for evaluation of public health programmes in complex adaptive systems. Theory-based and mixed-methods approaches will be used to investigate the fidelity of the ActEarly research programme, and whether, why and how ActEarly contributes to changes in the policy system, and whether alternative explanations can be ruled out. Ripple effects and systems mapping will be used to explore the relationships between interventions and their outcomes, and the degree to which the ActEarly programme encouraged interdisciplinary and prevention research collaboration as intended. A computer simulation model ("LifeSim") will also be used to evaluate the scale of the potential long-term benefits of cross-sectoral action to tackle the financial, educational and health disadvantages faced by children in Bradford and Tower Hamlets. Together, these approaches will be used to evaluate ActEarly's dynamic programme outputs at different system levels and measure the programme's system changes on early life health and well-being. This meta-evaluation protocol presents our plans for using and adapting the ENCOMPASS framework to evaluate the system-wide impact of the early life health and well-being programme, ActEarly. Due to the collaborative and non-linear nature of the work, we reserve the option to change and query some of our evaluation choices based on the feedback we receive from stakeholders to ensure that our evaluation remains relevant and fit for purpose.

Identifiants

pubmed: 37262082
doi: 10.1371/journal.pone.0280696
pii: PONE-D-22-35164
pmc: PMC10234514
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0280696

Subventions

Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Chief Scientist Office
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Mansukoski et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trials. 2020 Sep 10;21(1):774
pubmed: 32912308
Int J Behav Nutr Phys Act. 2022 Mar 28;19(1):33
pubmed: 35346233
BMC Public Health. 2021 Dec 18;21(1):2296
pubmed: 34922508
BMC Health Serv Res. 2019 Nov 29;19(1):912
pubmed: 31783853
Wellcome Open Res. 2019 Oct 14;4:156
pubmed: 31840089
Health Technol Assess. 2021 Sep;25(57):1-132
pubmed: 34590577
BMC Public Health. 2021 Oct 19;21(1):1888
pubmed: 34666742
J Mix Methods Res. 2010 Sep 20;4(4):342-360
pubmed: 22167325
BMC Public Health. 2018 Jul 13;18(1):869
pubmed: 30005611
Health Expect. 2021 Aug;24(4):1158-1167
pubmed: 33942948
Evaluation (Lond). 2016 Jul;22(3):286-303
pubmed: 27478401
Am J Public Health. 2014 Jul;104(7):1270-8
pubmed: 24832406
BMJ. 2017 Jul 26;358:j3310
pubmed: 28747304
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Lancet Reg Health Eur. 2021 Nov 30;13:100279
pubmed: 35199082
PLoS Med. 2020 Nov 2;17(11):e1003368
pubmed: 33137099
Int J Epidemiol. 2013 Aug;42(4):978-91
pubmed: 23064411
Wellcome Open Res. 2022 Jan 27;7:26
pubmed: 36466951
BMC Med Res Methodol. 2022 Mar 18;22(1):72
pubmed: 35300619
Nature. 2001 Mar 8;410(6825):268-76
pubmed: 11258382
Wellcome Open Res. 2020 Aug 13;5:191
pubmed: 33029561
PLoS One. 2021 Feb 12;16(2):e0245577
pubmed: 33577596
BMJ Open. 2019 Oct 2;9(10):e029424
pubmed: 31578197

Auteurs

Liina Mansukoski (L)

Department of Health Sciences, University of York, York, United Kingdom.
Bradford Institute for Health Research, Bradford, United Kingdom.

Bridget Lockyer (B)

Bradford Institute for Health Research, Bradford, United Kingdom.

Amy Creaser (A)

Bradford Institute for Health Research, Bradford, United Kingdom.

Jessica Sheringham (J)

Department of Applied Health Research, University College London, London, United Kingdom.

Laura Sheard (L)

Department of Health Sciences, University of York, York, United Kingdom.

Philip Garnett (P)

The School for Business and Society, University of York, York, United Kingdom.

Tiffany Yang (T)

Bradford Institute for Health Research, Bradford, United Kingdom.

Richard Cookson (R)

Centre for Health Economics, University of York, York, United Kingdom.

Alexandra Albert (A)

NESTA, London, United Kingdom.

Shahid Islam (S)

Bradford Institute for Health Research, Bradford, United Kingdom.

Robert Shore (R)

Bradford Institute for Health Research, Bradford, United Kingdom.

Aiysha Khan (A)

Bradford Institute for Health Research, Bradford, United Kingdom.

Simon Twite (S)

Public Health Division, London Borough of Tower Hamlets, London, United Kingdom.

Tania Dawson (T)

The School for Business and Society, University of York, York, United Kingdom.

Halima Iqbal (H)

School of Nursing and Healthcare Leadership, University of Bradford, Bradford, United Kingdom.

Ieva Skarda (I)

Centre for Health Economics, University of York, York, United Kingdom.

Aase Villadsen (A)

Centre for Longitudinal Studies, University College London, London, United Kingdom.

Miqdad Asaria (M)

Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.

Jane West (J)

Bradford Institute for Health Research, Bradford, United Kingdom.

Trevor Sheldon (T)

Centre for Public Health & Policy, Queen Mary University of London, London, United Kingdom.

John Wright (J)

Bradford Institute for Health Research, Bradford, United Kingdom.

Maria Bryant (M)

Department of Health Sciences, University of York, York, United Kingdom.
Hull York Medical School, University of York, York, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH